Healthcare -
Biotechnology - NASDAQ - US
$ 14.69
3.89 %
$ 1.49 B
Market Cap
-4.1
P/E
DYN - COST OF REVENUE
Cost of Revenue DYN - Dyne Therapeutics, Inc.
2.46 M
LAST VALUE
50.40%
2 YEAR CAGR
152.45%
5 YEAR CAGR
-45.90%
10 YEAR CAGR